Evaluating the benefit of immunotherapy for Stage III melanoma
Published: 26 April 2024| Version 1 | DOI: 10.17632/7mrrdzh7dw.1
Contributors:
, Description
Supplemental Tables
Files
Categories
Dermatology, Epidemiology, Immunotherapy, Melanoma
Supplemental Tables